Overview

Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
To test the hypothesis that children/adolescents with ADHD, who are treated with atomoxetine hydrochloride in comparison to standard current therapies have greater improvements in their quality of life.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Atomoxetine Hydrochloride